Take a trial of UK to unlock this pageFind out more

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2009 2010 2011 2012 2013 2014 2015E 2016E CAGR / Avg
Revenue $m
Operating Profit $m
Net Profit $m
EPS Reported $
EPS Normalised $
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps $
Capex ps $
Free Cashflow ps $
Last ex-div: 16th Apr, paid: 6th May more... Dividends
Dividend ps $
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc $m
Working Capital $m
Net Fixed Assets $m
Net Debt $m
Book Value $m
Average Shares m
Book Value ps $ +13.0%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2014, Smith & Nephew plc revenues increased 6% to $4.62B. Net income decreased 10% to $501M. Revenues reflect Advance Surgical Devices segment increase of 9% to $3.3B, United States segment increase of 8% to $2.01B, Emerging and International Markets segment increase of 20% to $677M, United Kingdom segment increase of 2% to $299M. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 31st Dec '14) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2015
31st Dec 2016

Price Target: $18.0
(-0.071% below Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: +10.6% ($) (¢) (¢) ($) (¢) (¢)
Consensus Estimate
1m Change
3m Change
16 brokers Broker Consensus Trend
Broker Recommendations for Smith & Nephew
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 1 10 4 5

Named Brokers and Analysts
Jefferies Martin Brunninger , Credit Suisse Christoph Gretler , BERNSTEIN Lisa Bedell Clive , Investec Bank (UK) Plc Nicholas Keher , Canaccord Genuity William Plovanic , Brean Capital, LLC Jason Wittes , Nomura Securities , Panmure Gordon Savvas Neophytou , Numis Securities Sally Taylor , Edison Investment Research , Societe Generale Justin Smith , Berenberg Tom Jones , Charles Stanley Rae Ellingham , Shore Capital Stockbrokers Brian White , Morningstar, Inc. Debbie Wang , Day by Day Valérie GASTALDY , and 1 unnamed other

Profile Summary

Smith & Nephew plc is a global medical devices business operating in the markets for advanced surgical devices consisting orthopaedic reconstruction, trauma and sports medicine and advanced wound management. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The Company’s Advanced Surgical Devices (ASD) segment offers products and technologies include orthopaedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy enabling technologies and other ASD. The Company’s Advanced Wound Management (AWM) segment offers products include Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. The Company operates across the world and has distribution channels in over 90 countries.

Directors: Olivier Bohuon (CEO) 56, Julie Brown (CFO) 52, Rodrigo Bianchi (CEX) 55, Michael Frazzette (CEX) 53, R. Gordon Howe (CEX) 52, Diogo Moreira-Rato (CEX) 53, Glenn Warner (CEX) 52, John Campo (OTH) 60, Helen Maye (OTH) 55, Cyrille Petit (OTH) 44, Roberto Quarta (NEC) 64, Vinita Bali (NID) 59, Ian Barlow (NID) 63, Virginia Bottomley (NID) 67, Erik Engstrom (NID) 51,

No. of Employees: 13,468 No. of Shareholders: 17,824

Last Annual December 31st, 2014
Last Interim December 31st, 2014
Shares in Issue 895,905,480
Free Float 890.3m (99.4%)

SN. Share Price Performance SN.Quote
-16.0  -1.4%
Traded 4:37pm · Minimum 15 min delayed · NMS: 2.00k

Latest SN. News Announcements (delayed)

Upcoming SN. Events
Thursday 30th April, 2015
Q1 2015 Smith & Nephew PLC Trading Statement Release
Thursday 30th April, 2015
Q1 2015 Smith & Nephew PLC Trading Statement Call
Thursday 30th July, 2015
Q2 2015 Smith & Nephew PLC Earnings Release
Thursday 29th October, 2015
Q3 2015 Smith & Nephew PLC Trading Statement Release
Friday 8th April, 2016 (estimate)
Smith & Nephew PLC Annual Shareholders Meeting

Recent ↓
Wednesday 15th April, 2015
Dividend For SNN
Thursday 9th April, 2015
Smith & Nephew PLC Annual Shareholders Meeting
Wednesday 25th March, 2015
Smith & Nephew PLC Analyst & Investor Breakfast
Wednesday 25th March, 2015
Smith & Nephew PLC at Canaccord Genuity Musculoskeletal Conference
Thursday 5th February, 2015
Q4 2014 Smith & Nephew PLC Earnings Call
Thursday 5th February, 2015
Q4 2014 Smith & Nephew Earnings Release
Monday 12th January, 2015
Smith & Nephew PLC at JPMorgan Healthcare Conference
Monday 12th January, 2015
Smith & Nephew PLC at JPMorgan Healthcare Conference
Thursday 4th December, 2014
Smith & Nephew PLC at Berenberg European Conference
Tuesday 11th November, 2014
Smith & Nephew PLC Capital Markets Event

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2015.

Should you buy SN.

Access SN. Analytics Now!